BioSpace News Archive

Activate Healthcare’s on-site and near-site health clinic business was recognized by KLAS, in their 2018 Worksite Health Service report, as the top performer for three important measures including overall performance, quality of staff and strategic expertise.

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the indication for Xtandi (enzalutamide) to include adult men with high-risk non-metastatic castration-resistant prostate cancer (nmCRPC)

Epic Sciences, in partnership with Memorial Sloan Kettering (MSK), have demonstrated that a liquid biopsy blood test may be used in clinical trials to find patients who are likely to benefit from PSMA-targeted therapies, before treatment is initiated

MedeAnalytics, a pioneer in healthcare analytics, today announced that the company is celebrating its 25th anniversary.

INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE) (OTCQX: IVITF) (FRA: 8IS1) is pleased to provide an update on its progress towards European Union Good Manufacturing Practices (“EU-GMP”) certification.

Applications are now being accepted for the fourth annual Northrop Grumman Foundation Teachers Academy.

84 percent of the patients it manages in Michigan have seen a primary care physician (PCP) in the last year, well above the national average of 51 percent

Goalkeepers Global Youth Poll reinforces role of youth in advancing the Global Goals

Fewer than one in five think their government is doing enough to tackle diabetes, finds International Diabetes Federation

New ASCO policy statement identifies multiple barriers and recommends path forward including steps to address coverage of costs and lack of patient support.